Related Experiment Video
Updated: Oct 17, 2025

A 3D Spheroid Model for Glioblastoma
Published on: April 9, 2020
Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids
Takayuki Morimoto1, Tsutomu Nakazawa1,2, Ryosuke Matsuda1
1Department of Neurosurgery, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Abstract:
Glioblastoma (GBM) is the most common and aggressive primary brain tumor, with a dismal prognosis. Natural killer (NK) cells are large granular lymphocytes with natural cytotoxicity against tumor cells, and they should be established for the novel treatment of patients with GBM. We previously reported highly activated, and ex vivo-expanded NK cells derived from human peripheral blood, designated genuine induced NK cells (GiNK), which were induced by specific culture conditions and which exerted a cytotoxic effect on GBM cells via apoptosis. Here, we comprehensively summarize the molecular characteristics, especially focusing on the expression of stem cell markers, extracellular matrix markers, chemokines, chemokine receptors, and NK receptor ligands of spheroids derived from GBM cell lines as compared with that of two-dimensional (2D) adherent GBM cells via microarray. The spheroid had upregulated gene expression of stem cell markers, extracellular matrix markers, chemokines, chemokine receptors, and NK cell inhibitory receptor ligands compared with the 2D adherent GBM cells. Preclinical evaluation of the NK cells was performed via an ex vivo 3D spheroid model derived from GBM cell lines. In the model, the NK cells accumulated and infiltrated around the spheroids and induced GBM cell death. Flow cytometry-based apoptosis detection clearly showed that the NK cells induced GBM cell death via apoptosis. Our findings could provide pivotal information for NK cell-based immunotherapy for patients with GBM.
Insights
Natural killer (NK) cells show promise in treating glioblastoma (GBM). Activated NK cells effectively infiltrate and induce apoptosis in 3D GBM spheroids, offering a potential immunotherapy strategy.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Glioblastoma (GBM) is an aggressive brain tumor with poor outcomes.
- Natural killer (NK) cells possess inherent cytotoxicity against tumor cells.
- Previous research established ex vivo-expanded NK cells (GiNK) that target GBM cells via apoptosis.
Purpose of the Study:
- To comprehensively analyze molecular differences between 2D and 3D GBM models.
- To evaluate the efficacy of GiNK cells against 3D GBM spheroids.
- To provide insights for NK cell-based glioblastoma immunotherapy.
Main Methods:
- Microarray analysis of gene expression in 2D vs. 3D GBM cell cultures.
- Characterization of stem cell markers, ECM markers, chemokines, receptors, and NK ligands.
- Preclinical evaluation of GiNK cell activity using an ex vivo 3D GBM spheroid model.
- Flow cytometry for apoptosis detection.
Main Results:
- 3D GBM spheroids exhibited upregulated gene expression of stem cell markers, ECM markers, chemokines, receptors, and NK inhibitory ligands compared to 2D cultures.
- GiNK cells infiltrated and accumulated around 3D GBM spheroids.
- GiNK cells effectively induced glioblastoma cell death through apoptosis.
Conclusions:
- 3D GBM spheroids present distinct molecular characteristics compared to 2D cultures.
- GiNK cells demonstrate significant anti-GBM activity in a 3D ex vivo model.
- These findings support the potential of NK cell-based immunotherapy for glioblastoma treatment.

